« FDA Approvals - FDA lifts warnings against 2 Medtronic plants, clearing way for | Main | FDA approves new treatment for a type of late-stage skin »

FDA approves Zostavax vaccine to prevent shingles in individuals 50


FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age
The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.
 

©2006 FDA-News.com. All rights reserved.